4.8 Article

British Society of Gastroenterology guidelines on the management of irritable bowel syndrome

期刊

GUT
卷 70, 期 7, 页码 1214-1240

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/gutjnl-2021-324598

关键词

-

向作者/读者索取更多资源

This guideline aims to review and summarize current evidence on irritable bowel syndrome (IBS) to inform clinical practice and provide guidance, with specific treatment recommendations based on evidence from a comprehensive search of medical literature. The guideline highlights the efficacy of dietary, pharmacological, and psychological therapies in treating IBS, and provides specific recommendations according to the Grading of Recommendations Assessment, Development, and Evaluation system.
Irritable bowel syndrome (IBS) remains one of the most common gastrointestinal disorders seen by clinicians in both primary and secondary care. Since publication of the last British Society of Gastroenterology (BSG) guideline in 2007, substantial advances have been made in understanding its complex pathophysiology, resulting in its re-classification as a disorder of gut-brain interaction, rather than a functional gastrointestinal disorder. Moreover, there has been a considerable amount of new evidence published concerning the diagnosis, investigation and management of IBS. The primary aim of this guideline, commissioned by the BSG, is to review and summarise the current evidence to inform and guide clinical practice, by providing a practical framework for evidence-based management of patients. One of the strengths of this guideline is that the recommendations for treatment are based on evidence derived from a comprehensive search of the medical literature, which was used to inform an update of a series of trial-based and network meta-analyses assessing the efficacy of dietary, pharmacological and psychological therapies in treating IBS. Specific recommendations have been made according to the Grading of Recommendations Assessment, Development and Evaluation system, summarising both the strength of the recommendations and the overall quality of evidence. Finally, this guideline identifies novel treatments that are in development, as well as highlighting areas of unmet need for future research.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Oncology

A systematic review of behavioural and exercise interventions for the prevention and management of chemotherapy-induced peripheral neuropathy symptoms

Mary Anne Lagmay Tanay, Jo Armes, Rona Moss-Morris, Anne Marie Rafferty, Glenn Robert

Summary: This study aimed to evaluate the effects of behavioral and exercise interventions on preventing or managing CIPN symptoms. The results showed that exercise interventions have beneficial effects on CIPN symptoms, although higher quality research is needed to confirm this. Behavioral interventions that increase patient's CIPN knowledge and improve self-management capacity can also reduce symptoms.

JOURNAL OF CANCER SURVIVORSHIP (2023)

Review Gastroenterology & Hepatology

Comparison of acid-lowering drugs for endoscopy negative reflux disease: Systematic review and network Meta-Analysis

Brigida Barberio, Pierfrancesco Visaggi, Edoardo Savarino, Nicola de Bortoli, Christopher J. Black, Alexander C. Ford

Summary: This study conducted a network meta-analysis to evaluate the efficacy and safety of different medical therapies for endoscopy-negative reflux disease. The results showed that proton pump inhibitors (PPIs) are superior to other drugs in treating this condition. Future research should focus on better patient classification and investigating the efficacy of other drugs.

NEUROGASTROENTEROLOGY AND MOTILITY (2023)

Review Gastroenterology & Hepatology

Efficacy and Safety of Drugs for Gastroparesis: Systematic Review and Network Meta-analysis

Maria Rosa Ingrosso, Michael Camilleri, Jan Tack, Gianluca Ianiro, Christopher J. Black, Alexander C. Ford

Summary: This study evaluated the efficacy and safety of drugs for gastroparesis through a network meta-analysis. The results showed that oral dopamine antagonists and tachykinin-1 antagonists were more effective than placebo. For individual symptoms, oral metoclopramide showed good efficacy for nausea, fullness, and bloating. However, the confidence in the evidence for most comparisons was low to moderate, indicating a need for more effective therapies for gastroparesis.

GASTROENTEROLOGY (2023)

Article Gastroenterology & Hepatology

Impact of Baseline Disease Activity and Trial Duration on Efficacy of Biologics in Active Crohn's Disease: Meta-analysis

Brigida Barberio, David J. Gracie, Christopher J. Black, Alexander C. Ford

Summary: In this study, the authors conducted a systematic review and meta-analysis to evaluate the impact of criteria used to define CD activity at study entry and the time point used to confirm efficacy on the therapeutic gain of active drug over placebo. The results showed that both factors appeared to be important in maximizing the treatment effect of active drug compared to placebo.

INFLAMMATORY BOWEL DISEASES (2023)

Editorial Material Gastroenterology & Hepatology

Editorial: ondansetron for patients with IBS-D and bowel-predominant symptoms-authors' reply

David Gunn, Alexander Ford, Amanda Farrin, Robin Spiller

Summary: This article is related to the papers by Gunn et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Letter Gastroenterology & Hepatology

Letter: Does irritable bowel syndrome have a greater impact in Western, compared with Asian, patients? Authors' reply

Vivek C. Goodoory, Elspeth A. Guthrie, Cho Ee Ng, Christopher J. Black, Alexander C. Ford

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Letter Gastroenterology & Hepatology

Letter: determining priorities for patients with faecal incontinence and irritable bowel syndrome--authors' reply

Vivek C. Goodoory, Cho E. Ng, Christopher J. Black, Alexander C. Ford

Summary: This article is associated with Goodoory et al papers. Click the link to access these articles.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Letter Gastroenterology & Hepatology

Relative Cost-effectiveness of Management Strategies for Uninvestigated Dyspepsia

Alexander C. Ford, Colin W. Howden

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

The national prevalence of disorders of gut brain interaction in the United Kingdom in comparison to their worldwide prevalence: Results from the Rome foundation global epidemiology study

Hussain Jaafari, Lesley A. Houghton, Robert M. West, Anurag Agrawal, Imran Aziz, Christopher J. Black, Maura Corsetti, Farag Shuweihdi, Maria Eugenicos, Peter A. Paine, Alexander C. Ford, Peter J. Whorwell, Shrikant I. Bangdiwala, Olafur S. Palsson, Ami D. Sperber, Dipesh H. Vasant

Summary: This study compared the prevalence of disorders of gut brain interaction (DGBI) in the UK with other countries and found that the proportion of DGBI participants was lower in the UK. The prevalence of 14 out of 22 Rome IV DGBI was similar between the UK and other countries, while some specific DGBI were more prevalent in the UK. Differences in opioid prescribing, cultural, dietary, and lifestyle factors may contribute to variations in the prevalence of DGBI between the UK and other countries.

NEUROGASTROENTEROLOGY AND MOTILITY (2023)

Review Gastroenterology & Hepatology

Improving access to gut-directed hypnotherapy for irritable bowel syndrome in the digital therapeutics' era: Are mobile applications a smart solution?

Syed S. Hasan, Sarah Ballou, Laurie Keefer, Dipesh H. Vasant

Summary: Gut-directed hypnotherapy (GDH) is a highly effective behavioral therapy recommended for the treatment of irritable bowel syndrome (IBS). GDH has been recognized as a valuable addition to integrated care alongside medical and dietary approaches. Recent innovations, such as smartphone app-delivered GDH, have improved access to this therapy despite low adherence rates.

NEUROGASTROENTEROLOGY AND MOTILITY (2023)

Article Gastroenterology & Hepatology

Novel symptom clusters predict disease impact and healthcare utilisation in inflammatory bowel disease: Prospective longitudinal follow-up study

Christy Riggott, Keeley M. Fairbrass, Christopher J. Black, David J. Gracie, Alexander C. Ford

Summary: Using latent class analysis, this study identified novel clusters of patients with inflammatory bowel disease (IBD) and found that patients with higher gastrointestinal and psychological symptoms were at a higher risk of adverse disease outcomes and were also high-volume users of healthcare.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Editorial Material Gastroenterology & Hepatology

Editorial: Recognising the regional variations in profile of irritable bowel syndrome-better late than never! Authors' reply

Kee-Huat Chuah, Christopher J. Black, Vincent Tee, Sze-Zee Lim, Wen-Xuan Hian, Nur-Fazimah Sahran, Yeong-Yeh Lee, Sanjiv Mahadeva, Alexander C. Ford

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Article Gastroenterology & Hepatology

The consequences of limited training in disorders of gut-brain interaction: Results from a national survey of gastroenterology trainees in the United Kingdom

Ayodele Sasegbon, Yuying Luo, Laurie A. Keefer, Dipesh H. Vasant

Summary: Despite the high prevalence and burden of disorders of gut-brain interaction (DGBI), there is limited teaching on this topic in medical curricula. This study evaluated the exposure and comfort levels of UK gastroenterology trainees in diagnosing and managing DGBI. Findings suggest that most trainees lack confidence in dealing with DGBI.

NEUROGASTROENTEROLOGY AND MOTILITY (2023)

Editorial Material Gastroenterology & Hepatology

Neurogastroenterology and Motility gets younger!

Maura Corsetti, Andrea Shin, Christopher Black, Daniel Keszthelyi, Fedias L. Christofi, Frank Zerbib, Kirsteen Browning, Michael Jones

NEUROGASTROENTEROLOGY AND MOTILITY (2023)

Article Neurosciences

Validation of symptom measures in patients under investigation for postural orthostatic tachycardia syndrome (POTS): The Orthostatic Grading Scale (OGS) and the Symptom Screen for Small-fiber Polyneuropathy (SSS)

Iris Knoop, Annie S. K. Jones, Nicholas Gall, Joseph Chilcot, William Pascoe, Rona Moss-Morris

Summary: This study aims to evaluate the psychometric properties of the OGS and SSS as effective measurement instruments for patients with suspected and confirmed POTS.

AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2023)

暂无数据